Puretech Health PLC’s (PRTC) “Buy” Rating Reaffirmed at Peel Hunt

Puretech Health PLC (LON:PRTC)‘s stock had its “buy” rating reaffirmed by research analysts at Peel Hunt in a report released on Thursday. They presently have a GBX 259 ($3.26) target price on the stock. Peel Hunt’s target price points to a potential upside of 125.22% from the company’s previous close.

PRTC has been the topic of a number of other research reports. Numis Securities Ltd reiterated a “buy” rating and set a GBX 220 ($2.77) target price on shares of Puretech Health PLC in a research report on Thursday, December 15th. Jefferies Group LLC reissued a “buy” rating and issued a GBX 255 ($3.21) price objective on shares of Puretech Health PLC in a research note on Thursday, January 5th. Liberum Capital reissued a “buy” rating and issued a GBX 248 ($3.12) price objective on shares of Puretech Health PLC in a research note on Wednesday, December 21st. Finally, N+1 Singer reissued a “buy” rating and issued a GBX 243 ($3.06) price objective on shares of Puretech Health PLC in a research note on Wednesday, December 21st. Five research analysts have rated the stock with a buy rating, Puretech Health PLC has a consensus rating of “Buy” and an average target price of GBX 250.20 ($3.15).

Analyst Recommendations for Puretech Health PLC (LON:PRTC)

Puretech Health PLC (LON:PRTC) traded down 0.43% during mid-day trading on Thursday, hitting GBX 114.50. 65,334 shares of the stock traded hands. The stock’s market cap is GBX 266.46 million. Puretech Health PLC has a 1-year low of GBX 110.00 and a 1-year high of GBX 170.00. The company’s 50 day moving average price is GBX 114.47 and its 200-day moving average price is GBX 122.98.

TRADEMARK VIOLATION WARNING: “Puretech Health PLC’s (PRTC) “Buy” Rating Reaffirmed at Peel Hunt” was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.chaffeybreeze.com/2017/04/21/puretech-health-plc-prtc-given-buy-rating-at-peel-hunt-updated.html.

Puretech Health PLC Company Profile

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Receive News & Ratings for Puretech Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply